NCT03776851View on ClinicalTrials.gov

Erythropoietin in Hemolytic Uremic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Hemolytic-Uremic SyndromeAnemia
Interventions
DRUG

erythropoietin

erythropoietin 50 International Units (IU) per kilogram three times weekly by subcutaneous route

Trial Locations (1)

1417

HGNPE, CABA

All Listed Sponsors
lead

Hospital General de Niños Pedro de Elizalde

OTHER

NCT03776851 - Erythropoietin in Hemolytic Uremic Syndrome | Biotech Hunter | Biotech Hunter